Basic Information
Basic information for LINC02232-201-44aa-2
Peptide Name LINC02232-201-44aa-2
Genome Position chr4:64916458-64916589[-]
Species Human
Peptide Sequence MFDFTKNKSSVNQNTHKIQLLQQNIIKTNNLLKWEKCLNTHFIH
Peptide Length 44
Unique No (LINC02232-204-44aa)
Grand Average of Hydropathicity -0.6773
Relative Molecular Mass 6086.95
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000250125;LINC02232
Transcript ID/Name ENST00000509932;LINC02232-201
Transcript Length 4460
Coding Ability 0.437
DNA Sequence Corresponding to Peptide ATGTTTGACTTTACCAAAAACAAATCATCAGTGAATCAAAATACTCACAAAATACAACTCCTACAGCAAAACATTATAAAGACAAACAACCTTTTAAAATGGGAAAAATGTTTGAACACACATTTTATACAT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :